Study guide

5.4 Controlled Substance Prescription Schedules & Validity

Tennessee MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Tennessee MPJE Blueprint

1.1 Exam Format, CAT Mechanics, Registration & Blueprint Overview 1.2 Tennessee Legal Architecture & Statutory Hierarchy

2 Chapter 2: Federal Regulatory Foundations for Pharmacy

2.1 Pure Food and Drug Act through FDCA, Durham-Humphrey & Kefauver-Harris 2.2 Controlled Substances Act (CSA) Schedules, Registration & Quotas 2.3 Federal Consumer Protection, HIPAA & OBRA '90

3 Chapter 3: Tennessee Board of Pharmacy & Personnel Licensure

3.1 Tennessee Board of Pharmacy Structure, Membership & Powers 3.2 Pharmacist Licensure, Reciprocity, Inactive Status & CE 3.3 Pharmacy Interns, Technicians & Supervision Ratios

4 Chapter 4: Pharmacy Practice Site Requirements & Facility Standards

4.1 Practice Site Licensing, Physical Specs & Security 4.2 Pharmacist-in-Charge (PIC) Responsibilities & Operational Governance 4.3 Manufacturers, Wholesalers, 503B Outsourcing Facilities & 3PLs 4.4 Drug Storage, Delivery & Non-Resident Pharmacy Obligations

5 Chapter 5: Prescriber Authority, Prescription Issuance & Tennessee Opioid Mandates

5.1 Prescribing Authority in Tennessee 5.2 Valid Prescription Elements & Transmission Standards 5.3 Tennessee Together Opioid Prescribing & Dispensing Restrictions 5.4 Controlled Substance Prescription Schedules & Validity

6 Chapter 6: Expanded Pharmacist Practice, CPPAs & Clinical Services

6.1 Collaborative Pharmacy Practice Agreements (CPPA) 6.2 Pharmacist Administration & Immunization Protocols 6.3 Hormonal Contraceptives, Naloxone & Public Health Protocols

7 Chapter 7: Controlled Substance Monitoring Database (CSMD) & Prescription Validation

7.1 Tennessee CSMD Statutory Mandates & Dispenser Reporting 7.2 Mandatory CSMD Checks & Prescriber/Dispensers Obligations 7.3 Corresponding Responsibility, Drug Diversion & Red Flags

8 Chapter 8: Dispensing Standards, Labeling, Substitution & Transfers

8.1 Dispensing Mechanics, Refill Authorizations & Emergency Fills 8.2 Labeling Requirements, Packaging & PPPA Compliance 8.3 Generic Substitution, Biosimilars & Interchangeability 8.4 Prescription Transfers & Shared Database Systems 8.5 Patient Counseling, Patient Profiles & Drug Regimen Review 8.6 Returning & Reusing Drugs: Destruction, Donation & Charitable Clinic Pharmacies

9 Chapter 9: Controlled Substance Ordering, Inventory & Recordkeeping

9.1 Controlled Substance Ordering: DEA Form 222 & CSOS 9.2 Controlled Substance Inventory Requirements 9.3 Record Retention, Filing Systems & Central Recordkeeping

10 Chapter 10: Sterile & Non-Sterile Compounding Regulations (USP 795/797/800)

10.1 Tennessee Board Rule 1140-07 & Sterile Product Preparation 10.2 USP 795, 797 & 800 Integration 10.3 Compounding vs Manufacturing & 503A vs 503B Facilities

11 Chapter 11: Institutional, Long-Term Care & Automated Pharmacy Practice

11.1 Institutional Pharmacy Practice Sites (Rule 1140-04) 11.2 Long-Term Care Pharmacy & Emergency Drug Supply 11.3 Telepharmacy, FQHC Clinics & Automated Dispensing Devices

12 Chapter 12: Controlled Substance Security, Disciplinary Action & Pharmacy Inspections

12.1 Controlled Substance Loss, Theft & Disposal 12.2 Pseudoephedrine Sales & NPLEx Tracking 12.3 Board Inspections, Disciplinary Grounds, Penalties & TPRN 12.4 Nonprescription, Behind-the-Counter & Restricted OTC Dispensing 12.5 Outdated, Deteriorated & Recalled Drugs: Conditions Prohibiting Dispensing

5.4 Controlled Substance Prescription Schedules & Validity

Key Takeaways Explain This Topic AI

Schedule II controlled substance prescriptions cannot be refilled under any circumstances under both federal (21 CFR § 1306.12) and Tennessee law (T.C.A. § 53-11-308); while Tennessee does not set an arbitrary calendar expiration date, pharmacists maintain corresponding responsibility to ensure clinical validity.

Under 21 CFR § 1306.12, a prescriber may issue multiple sequential Schedule II prescriptions on the same date for up to a 90-day total supply, provided each prescription bears the true date of issuance and explicit 'do not fill before' instructions without post-dating.

Schedule III and IV controlled substance prescriptions are valid for a maximum of 6 months from the date of issuance and may not exceed 5 refills; federally, Schedule V refills are as the prescriber authorizes.

Under CARA (21 CFR § 1306.13(b)), patient- or prescriber-requested partial fills of Schedule II prescriptions permit dispensing the remaining balance for up to 30 days from the original written issuance date.

For terminally ill patients and Long-Term Care Facility (LTCF) residents, Schedule II partial fills are valid for up to 60 days from the date of issuance, requiring rigorous audit documentation on the prescription or electronic record.

Last updated: November 2026

5.4 Controlled Substance Prescription Schedules & Validity

Quick Answer: Under federal law ( 21 CFR Part 1306 ) and Tennessee law ( T.C.A. Title 53, Chapter 11 ), Schedule II prescriptions can NEVER be refilled . While Tennessee statute does not establish a rigid arbitrary calendar expiration (e.g., 30 or 90 days) for Schedule II orders, the pharmacist bears corresponding responsibility to ensure the prescription serves an ongoing, legitimate medical purpose. Prescribers may issue sequential Schedule II prescriptions for up to a 90-day total supply , provided each is dated with the actual date of issuance and contains explicit "Do not fill before" dates. Schedule III and IV prescriptions are valid for 6 months with up to 5 refills , while federally Schedule V refills are as the prescriber authorizes . Under CARA , patient-requested Schedule II partial fills can be completed for up to 30 days from the date written ; out-of-stock partial fills must be completed within 72 hours ; and LTCF/terminally ill partial fills are valid for 60 days .

1. Controlled Substance Scheduling & Validity Summary Matrix

The following matrix summarizes the core validity parameters across all controlled substance schedules in Tennessee:

Schedule Refill Limits Maximum Statutory Validity Window Verbal (Oral) Orders Permitted? Facsimile (Fax) Original Permitted? Emergency Partial Fill Rules

Schedule II (C-II) ZERO (0) Refills No arbitrary calendar cutoff in TN; pharmacist assesses timeliness NO (Emergency only; 7-day cover required) NO (Except Home Infusion IV, LTCF, and Hospice) • CARA (Patient/prescriber request): 30 days from written date ; • Out-of-Stock: 72 hours ; • LTCF / Terminally Ill: 60 days from issue date

Schedule III (C-III) Max 5 refills 6 Months from date of issuance YES (Pharmacist/intern reduces to writing) YES (Serves as original order) Partial fills permitted within the 6-month validity window ; partial fills do not count as full refills.

Schedule IV (C-IV) Max 5 refills 6 Months from date of issuance YES (Pharmacist/intern reduces to writing) YES (Serves as original order) Partial fills permitted within the 6-month validity window ; partial fills do not count as full refills.

Schedule V (C-V) As authorized No federal refill time limit (21 CFR 1306.22 covers III–IV) YES (Pharmacist/intern reduces to writing) YES (Serves as original order) Partial fills permitted up to the total authorized quantity, with no dispensing more than 6 months after issue (21 CFR 1306.23).

  • 2. Schedule II Controlled Substance Prescriptions
  • The Absolute Ban on Refills

Under 21 CFR § 1306.12 and T.C.A. § 53-11-308 , the refilling of a prescription for a Schedule II controlled substance is absolutely prohibited . If a patient requiring long-term C-II therapy (e.g., methylphenidate for ADHD or oxycodone for severe cancer pain) finishes their medication, a completely new prescription must be issued.

Prescription Expiration in Tennessee

Unlike some jurisdictions that enforce a fixed 30-day, 60-day, or 6-month statutory expiration on Schedule II prescriptions, Tennessee pharmacy law does not define an arbitrary calendar expiration date for Schedule II prescriptions . However, this does NOT mean a Schedule II prescription is valid indefinitely:

Under the doctrine of Corresponding Responsibility (21 CFR § 1306.04) , the pharmacist must determine whether a Schedule II prescription presented weeks or months after issuance remains clinically appropriate and serves a legitimate medical need.

If a patient presents a Schedule II prescription written 4 months prior for post-extraction tooth pain, the pharmacist must refuse to dispense it because acute dental pain cannot legitimately persist months later without re-evaluation.

Multiple Sequential Schedule II Prescriptions (21 CFR § 1306.12)

To alleviate the burden on chronic pain or ADHD patients who previously had to visit their physician every 30 days, federal DEA regulations allow prescribers to issue multiple prescriptions for the same Schedule II substance on a single office visit , allowing the patient to receive up to a total of a 90-day supply , subject to strict compliance rules: ┌─────────────────────────────────────────────────────────────────────────────┐

  • │ RULES FOR ISSUING SEQUENTIAL SCHEDULE II PRESCRIPTIONS │
  • ├─────────────────────────────────────────────────────────────────────────────┤
  • │ 1. Maximum Cumulative Supply: Up to a total 90-day supply (e.g., three │
  • │ separate 30-day prescriptions). │
  • │ 2. Actual Date of Execution: EVERY prescription must bear the ACTUAL date on│
  • │ which it was physically written and signed. Post-dating is ILLEGAL. │
  • │ 3. Earliest Fill Date Instructions: Prescriptions #2 and #3 must contain │
  • │ explicit written instructions: "Do not fill before [earliest fill date]". │
  • │ 4. No Premature Dispensing: A pharmacist cannot dispense any prescription │
  • │ prior to the specified "do not fill before" date. │
  • │ 5. Legitimate Medical Purpose: The prescriber must conclude that sequential │
  • │ issuance does not create an undue risk of diversion or abuse. │
  • └─────────────────────────────────────────────────────────────────────────────┘

Caution

The Post-Dating Trap: A prescriber sees a patient on September 5, 2026 , and writes three prescriptions for Adderall 20 mg. If the prescriber dates the first prescription September 5, the second October 5, and the third November 5, the second and third prescriptions are legally INVALID . Under 21 CFR § 1306.05, post-dating is illegal. The prescriber MUST write "Date Issued: September 5, 2026" on ALL THREE , with "Do not fill before October 5, 2026" written on the second, and "Do not fill before November 5, 2026" on the third.

  • 3. Schedule III, IV, and V Prescriptions
  • Schedules III and IV (T.C.A. § 53-11-308 & 21 CFR § 1306.22)

Maximum Refills: May not be filled or refilled more than five (5) times .

Expiration Window: Valid for a maximum of six (6) months from the date on which the prescription was issued.

Whichever Occurs First Rule: If 6 months have elapsed since issuance, all remaining refills are permanently void, even if the patient only used 2 of the 5 authorized refills. Conversely, if the patient exhausts all 5 refills within 3 months, the prescription is expired.

Refill vs. Partial Fill: A partial fill of a Schedule III or IV prescription is NOT counted as a full refill . For example, if a prescription is written for Ambien (zolpidem) 10 mg #30 with 5 refills, and the patient requests 15 tablets, this partial dispensing counts only toward the total quantity authorized (up to 180 tablets total), provided all dispensing occurs within 6 months from the date of issuance.

Schedule V Prescriptions

Federally, Schedule V prescriptions (e.g., pregabalin, lacosamide, promethazine with codeine) may be refilled as authorized by the prescriber; the five-refill, six-month limit in 21 CFR 1306.22 covers Schedules III and IV only.

4. Comprehensive Partial Filling Mechanics for Schedule II Drugs

Partial filling of Schedule II controlled substances is heavily tested on the MPJE and is governed by three distinct legal frameworks: ┌─────────────────────────────────────────────────────────────────────────────┐

  • │ SCHEDULE II PARTIAL FILL FRAMEWORKS │
  • ├─────────────────────────────────────────────────────────────────────────────┤
  • │ 1. CARA (Patient or Prescriber Requested Partial Fill) │
  • │ • Statutory Basis: Comprehensive Addiction and Recovery Act (CARA) │
  • │ • Trigger: Requested by the patient or directed by the prescriber. │
  • │ • Time Limit: Remainder may be filled up to 30 DAYS FROM WRITTEN DATE. │
  • ├─────────────────────────────────────────────────────────────────────────────┤
  • │ 2. Out-of-Stock (Pharmacy Unable to Supply Full Quantity) │
  • │ • Statutory Basis: 21 CFR § 1306.13(a) │
  • │ • Trigger: Pharmacy has insufficient inventory to supply full order. │
  • │ • Time Limit: Remainder must be dispensed within 72 HOURS of first fill. │
  • │ • Consequence if missed: Remainder forfeited; notify prescriber. │
  • ├─────────────────────────────────────────────────────────────────────────────┤
  • │ 3. LTCF Resident or Terminally Ill Patient │
  • │ • Statutory Basis: 21 CFR § 1306.13(c) │
  • │ • Trigger: Patient resides in LTCF or has documented terminal illness. │
  • │ • Time Limit: Partial fills permitted for up to 60 DAYS FROM ISSUE DATE. │
  • │ • Mandatory Notation: Must record "LTCF Patient" or "Terminally Ill". │
  • └─────────────────────────────────────────────────────────────────────────────┘
  • Framework 1: CARA Patient/Prescriber Requests (21 CFR § 1306.13(b))

Enacted under Section 705 of the Comprehensive Addiction and Recovery Act (CARA) and adopted into DEA rules:

If requested by the patient or directed by the prescriber, a pharmacist may partially fill a Schedule II prescription.

The 30-Day Clock: Any remaining portion of the prescription may be filled, but all partial fills must occur within thirty (30) days from the DATE THE PRESCRIPTION WAS WRITTEN (issued) .

Critical MPJE Distinction: The 30 days run from the date of issuance , NOT from the date of the first partial fill! If an order is written on October 1 and the patient receives a partial fill on October 20, the patient only has until October 31 (30 days from October 1) to receive the balance.

The total quantity dispensed in all partial fills cannot exceed the total quantity originally prescribed.

Framework 2: Pharmacy Out-of-Stock (21 CFR § 1306.13(a))

When the pharmacy has insufficient stock on hand to fulfill a Schedule II prescription:

The pharmacist must record the quantity supplied on the face of the written prescription or in the electronic database.

The 72-Hour Rule: The remaining portion of the prescription must be dispensed within seventy-two (72) hours of the initial partial filling .

If the remaining portion is not or cannot be supplied within the 72-hour window, the pharmacist must notify the prescriber. The remaining quantity is permanently forfeited , and no further quantity may be dispensed without a new prescription.

Framework 3: LTCF Residents & Terminally Ill Patients (21 CFR § 1306.13(c))

Recognizing that patients in long-term care or terminal hospice care frequently have rapidly fluctuating dosages or high mortality:

Pharmacists may dispense partial quantities of Schedule II prescriptions for patients in a Long-Term Care Facility (LTCF) or patients with a documented terminal illness.

Mandatory Annotation: The pharmacist must record "LTCF Patient" or "Terminally Ill" on the prescription record. Dispensing without this notation is a federal violation.

The 60-Day Window: Partial fills for LTCF or terminally ill patients are valid for a maximum of sixty (60) days from the date of issuance .

Audit Documentation: For each partial fill, the pharmacist must record: (1) date of partial fill, (2) quantity dispensed, (3) remaining quantity authorized, and (4) the identification of the dispensing pharmacist.